NPS Pharmaceuticals Expands Executive Leadership Team to Support Its US …

Published March 27, 2014

NPS Pharmaceuticals Expands Executive Leadership Team to Support its US …
Cinryze was launched in December 2008 and generated $ 97 million in first-year sales, making it one of the most successful orphan drug launches in the U.S. Prior to ViroPharma, Mr. Firuta held commercial leadership positions at OraPharma, Inc. and …
Read more on Business Wire (press release)

FDA Approves New Pill for Psoriatic Arthritis
“This is an important advance,” says John Hardin, MD, vice president of research for the Arthritis Foundation and professor of medicine at Albert Einstein College of Medicine in New York. “We now have an … Treatment involves treating joint and skin …
Read more on Arthritis Today

More Drug Treatment Programs Maryland Information…